Fatty liver is the most common type of liver disease, affecting nearly one third of the U.S. population and more than half a billion people worldwide. Abnormalities in endoplasmic reticulum (ER) calcium handling and mitochondrial function each have been implicated in abnormal lipid droplet formation. Here we show that the type 1 isoform of the inositol 1,4,5-trisphosphate receptor (InsP 3 R1) specifically links ER calcium release to mitochondrial calcium signaling and lipid droplet formation in hepatocytes. Moreover, liver-specific InsP 3 R1 knockout mice have impaired mitochondrial calcium signaling, decreased hepatic triglycerides, and reduced lipid droplet formation and are resistant to the development of fatty liver. Patients with nonalcoholic steatohepatitis, the most malignant form of fatty liver, have increased hepatic expression of InsP 3 R1, and the extent of ER-mitochondrial colocalization correlates with the degree of steatosis in human liver biopsies. Conclusion: InsP 3 R1 plays a central role in lipid droplet formation in hepatocytes, and the data suggest that it is involved in the development of human fatty liver disease. (HEPATOLOGY COMMUNICATIONS 2017;1:23-35) 
Introduction N onalcoholic fatty liver disease (NAFLD) is the most common form of chronic liver disease worldwide, affecting more than 25% of the global population.
(1) Prevalence in Europe and the US may be as high as one in three individuals. (1) Although many individuals with NAFLD have simple hepatic steatosis, a subset also develop hepatic inflammation, termed nonalcoholic steatohepatitis (NASH). Those patients are at particularly high risk to progress to cirrhosis and hepatocellular carcinoma, (1) the third leading cause of cancer death worldwide. (2) NAFLD is often, but not always, associated with obesity and diabetes (3) and is an independent risk factor for coronary artery disease. (4, 5) Recent studies using several different animal models implicate abnormal handling of calcium (Ca 21 ) by the endoplasmic reticulum (ER) (6) (7) (8) or mitochondrial dysfunction (9) (10) (11) as the basis for aberrant lipid accumulation in hepatocytes. Ca 21 signals have well-established importance in the cascade of events linking hormonal signaling to metabolic processes in the liver, (12) (13) (14) and the inositol 1,4,5 trisphosphate receptor (InsP 3 R) is the only intracellular calcium release channel in hepatocytes. (15) There are three InsP 3 R isoforms, with varying sensitivity to Ca 21 and inositol 1,4,5 trisphosphate (InsP 3 ) and distinct tissue and subcellular expression patterns. (16) In hepatocytes, the predominant isoforms are InsP 3 R1
and InsP 3 R2, with the latter being most concentrated in the region of the ER along the apical (canalicular) membrane. (15) Conversely, InsP 3 R1 is diffusely distributed throughout the cytoplasm. (15) Ca 21 homeostasis, and more specifically InsP 3 R, plays an important role in metabolic pathways in the liver, but isoform-specific effects are not well characterized. (7, (17) (18) (19) (20) Although InsP 3 R2 is the predominant isoform in hepatocytes (15) and is important for regulating bile secretion, (21, 22) InsP 3 R2 knockout (KO) mice have no apparent metabolic phenotype. (23) Therefore, we examined the role of InsP 3 R1 in hepatic steatosis. Given the nearly ubiquitous expression of InsP 3 R1, (16) in addition to the fact that whole body InsP 3 R1 KO mice die in the perinatal period, (24) a hepatocyte-specific KO was generated to appropriately interrogate the metabolic role of InsP 3 R1 in the liver.
Materials and Methods

MOUSE STRAINS AND ISOLATION AND SANDWICH CULTURE OF MOUSE HEPATOCYTES
Floxed InsP 3 R1 mice were created and imported from our colleagues in the laboratory of Andrew Marks at Columbia University. Briefly, exon 4, the second coding exon of the Itpr1 gene, encoding InsP 3 R1, was flanked with loxP sites. The final InsP 3 R1 flox/flox mice were crossed for six generations onto a C57/bl6 background. InsP 3 R1 flox/flox mice were crossed with AlbCre mice to obtain InsP 3 R1 Cre: flox/1 mice, which were backcrossed with InsP 3 R1 flox/flox mice to generate Cre: flox/flox mice. Breeders from the second generation of the crossing of Cre: flox/flox mice were used for experiments. Male littermate flox/flox and Cre: flox/flox Livers were minced and passed through a 40-mm nylon mesh filter, and the resultant cells were washed. Isolated hepatocytes were resuspended in complete Williams medium E. Cells were then seeded onto collagen-I-coated coverslips and incubated at 378C for 2 hours before transfection with plasmids. Cells were coated with a second layer of collagen-I 24 hours after transfection and were used in the experiments 96 hours after plating. All experimental procedures and euthanasia were approved by the Institutional Animal Care and Use Committee. optical imaging R-GECO (25) 
IN VIVO METABOLIC STATE ANALYSIS
Male littermate mice (age, 10-12 weeks) were individually housed and given 2 weeks to acclimate to the calorimetric apparatus (TSE Systems, Bad Homburg, Germany). The environment was temperature controlled (238C) and lighting was restricted to a 12-hour light/dark cycle with free access to food and water. The comprehensive animal metabolic monitoring system (CLAMS; Columbus Instruments) was used to evaluate physical activity, food consumption, and energy expenditure. Energy expenditure and respiratory exchange ratio were calculated from the gas exchange data [energy expenditure 5 (3.815 1 1.232 3 RER) 3 VO 2 ], with RER determined as the ratio of VCO 2 to VO 2 . Activity was measured in horizontal and vertical directions using infrared beams to count the beam breaks during a specified period. Feeding was measured by recording the difference in the scale measurement of the center feeder from one time point to another. Drinking was assessed by way of an automated system counting consumed water droplets.
Plasma triglyceride levels were measured using Triglyceride-SL detection reagent (Sekisui Diagnostics, Lexington, MA). Liver triglycerides were determined using the Triglyceride-SL detection reagent after tissue homogenization and lipid extraction in chloroform/methanol (2:1), followed by acidification with H 2 SO 4 and phase separation by way of centrifugation.
HYPERINSULINEMIC-EUGLYCEMIC CLAMP STUDIES
Hyperinsulinemic-euglycemic (HE) clamp studies were performed as described previously (26) and in accordance with recommendations provided by the Mouse Metabolic Phenotyping Consortium. (27) These experiments were performed by the Yale Mouse Metabolic Phenotyping Center Analytical Core. Surgical implantation of a right jugular vein catheter was performed 1 week prior to HE clamp studies, allowing mice time to recover. Mice were fasted overnight for 14 hours and in the morning were continuously infused with 0.05 lCi/min 3-[ 3 H]glucose for 2 hours to assess basal glucose turnover. HE clamping was conducted for 140 minutes with a primed/continuous infusion of human insulin (Novolin; Novo Nordisk, Princeton, NJ) and a variable infusion of 20% dextrose to maintain euglycemia (120 mg/dL).
For the insulin prime, insulin was infused simultaneous to infusion of 3-[ 3 H]glucose at a rate of 7.14 mU/kg/min for 4 min. Then the insulin infusion rate was dropped to 3 mU/kg/min for the remainder of the experiment. 3-[ 3 H]glucose was continuously infused at a rate of 0.1 lCi/min to determine insulin stimulated glucose uptake and endogenous glucose production after the basal period. A 10 lCi bolus of [ 14 C]2-deoxyglucose was injected after 90 minutes to estimate the insulin-stimulated tissue-specific glucose uptake. Blood samples were taken at 0 and 135 min for plasma fatty acid and insulin concentrations. At the end of the study, mice were anesthetized with an intravenous injection of 150 mg/kg pentobarbital and tissues were harvested, frozen in liquid nitrogen, and stored at 2808C until later analysis.
Basal and insulin-stimulated whole body glucose turnover rates were calculated as ( [3- 3 H]glucose infusion (in dpm)/(plasma glucose specific activity (dpm per mg)) at the end of the basal period and during the final 40 min of the clamp, respectively. Endogenous glucose production 5 (rate of total glucose appearance) -(glucose infusion rate).
ANALYSIS OF SAMPLES FOR HUMAN STUDIES
Formalin-fixed, paraffin-embedded (FFPE) liver biopsy specimens from patients with histologically normal-appearing liver (n 5 5), simple steatosis (n 5 5), and NASH (n 5 4) were retrieved from the archived specimen bank of the Department of Pathology (Yale-New Haven Hospital). After deparaffinization and antigen retrieval with citrate buffer pH 6.0, samples were stained overnight with a combination of endoplasmic reticulum (protein disulfide isomerase [PDI] ) and mitochondrial (translocase of outer mitochondrial membrane 22 ) antibodies. Secondary antibodies were Alexa 488 and Alexa 555, respectively. A total of five images per specimen were collected at 403 magnification on a Leica SP8 STED 33 confocal microscope. Mander's colocalization coefficients (28) were calculated using the Intensity Correlation Analysis plug-in of ImageJ software based on five subcellular regions of interest (average area 5 7.58 6 0.14 lm 2 ) blindly selected in each field. Results are expressed as the mean 6 standard error of the mean (SEM). All human studies were approved by the Yale Human Investigation Committee.
EXPRESSION ANALYSIS BY REAL-TIME PCR
Total RNA was extracted from FFPE human biopsies and from frozen livers of WT and InsP 3 R1 LSKO mice using the RNeasy FFPE kit and RNeasy Mini Kit, respectively (Qiagen, Germantown, MD). After reverse transcription, relative messenger RNA (mRNA) expression of selected genes was quantified with Taqman primers in a ABI 7500 Real-time PCR system (ThermoFisher, Waltham, MA).
Results
LOSS OF InsP 3 R1 IN HEPATOCYTES LEADS TO REDUCED LIPID ACCUMULATION IN VITRO AND IN VIVO
Mice expressing Cre recombinase under the control of an albumin promoter were crossed with InsP 3 R1 fl/fl mice in which exon 4 of Itpr1 was flanked by loxP sites as described previously. (17) To confirm that the deletion was effective at the protein level, we performed western blot analyses on whole liver homogenate, which revealed that InsP 3 R1 protein is dramatically reduced in the livers of InsP 3 R1 liver-specific knockout (InsP 3 R1 LSKO) mice (Supporting Fig. S1a) . We attribute the residual expression of InsP 3 R1 in the InsP 3 R1 LSKO lanes to the use of whole liver homogenate in which other InsP 3 R1-expressing cells are present. Western blot analyses of total cell lysates of isolated hepatocytes from InsP 3 R1 LSKO mice showed complete absence of InsP 3 R1 (Supporting Fig.  S1a ). InsP 3 R1 LSKO mice developed normally and were determined to have normal basal metabolic rates, as demonstrated by measurements of energy expenditure, VO 2 , VCO 2 , and physical activity (Supporting Fig. S1b-h ). In order to evaluate the contribution of InsP 3 R1 to the development of hepatic steatosis, we fed mice a high-fat diet (HFD) (60% of calories from fat, Research Diets Inc.) that results in obesity and fatty liver. (29) The mice were placed on an HFD at 4 weeks of age. After 9 weeks on an HFD, body weights of InsP 3 R1
fl/fl and InsP 3 R1 LSKO littermates began to diverge and were significantly different at the last time point (Supporting Fig. S1i) . The results of body composition measurements demonstrate that after 10 weeks on an HFD, InsP 3 R1 LSKO were leaner than their InsP 3 R1 fl/fl littermates (Fig. 1A) . Liver histology demonstrated that InsP 3 R1 LSKO mice were also protected from hepatic steatosis, whereas littermate controls have marked steatosis in their livers over the same time period (Fig. 1B) . Serum and liver triglycerides were reduced in InsP 3 R1 LSKO mice as well (Fig.  1C,D) . To corroborate the in vivo findings, ex vivo InsP 3 R1 LSKO hepatocytes from chow-fed mice were incubated with oleic acid alongside hepatocytes from WT chow-fed mice. The results revealed reduced lipid droplet accumulation in hepatocytes lacking InsP 3 R1, as demonstrated by time-lapse confocal imaging of Bodipy fluorescence (Fig. 1E) .
To investigate the mechanism by which InsP 3 R1 promotes lipid accumulation in hepatocytes, we performed expression analysis by qPCR of key genes involved in lipogenesis and fatty acid oxidation. WT and InsP 3 R1 LSKO mice were subjected to 10 weeks of HFD feeding, after which the animals were overnight-fasted (16 hours) and total liver mRNA was isolated. As shown in Figure 1F , the absence of InsP 3 R1 was associated with decreased expression of lipogenic genes: sterol regulatory element-binding protein, peroxisome proliferator-activated receptor c, and (Fig.  2A) . In contrast, the amplitude of the mitochondrial Ca 21 responses were significantly diminished in the cells without InsP 3 R1 compared with WT hepatocytes, whereas cells lacking InsP 3 R2 were similar to WT hepatocytes (Fig. 2B) signaling (Fig. 2C) . To more directly test the role of each InsP 3 R isoform in hepatocyte Ca 21 signaling, caged InsP 3 was photoreleased while cytoplasmic and mitochondrial Ca 21 signals were monitored by timelapse confocal imaging. (15) A mitochondrial calcium signal was observed in 83% of the WT cells in which a cytosolic calcium signal was detected (n 5 12). A similar percentage of InsP 3 R2 KO hepatocytes in which there was a cytosolic signal had mitochondrial responses (85% of n 5 7 cells; P 5 0.56), whereas mitochondrial responses were observed in only 60% of InsP 3 R1 LSKO hepatocytes in which there was a cytosolic signal (n 5 10 cells; P 5 0.02). These studies provide supporting evidence that InsP 3 R1 plays a more direct role than InsP 3 R2 in generating mitochondrial calcium signals.
ER TO MITOCHONDRIA ASSOCIATION IS PRESERVED IN InsP 3 R1 LSKO HEPATOCYTES
Because the absence of InsP 3 Rs might disrupt the association of mitochondria and ER and thus decrease Ca 21 transfer into the mitochondria, we evaluated the association of these organelles by way of electron microscopy. The percentage of total mitochondrial length in proximity to ER membranes (distance 40 nm) was similar in WT and InsP 3 R1 LSKO mice (Fig. 3) . In addition, the total mitochondrial perimeter was unchanged in InsP 3 R1 LSKO hepatocytes when compared with WT cells (WT 8429 6 4339 nm versus InsP 3 R1 LSKO 9387 6 3138 nm). These results show that ER to mitochondria association is not disrupted in the absence of InsP 3 R1. Moreover, they suggest that the impaired mitochondrial Ca 21 signals in InsP 3 R1 LSKO hepatocytes are not a result of nonspecific dissociation of ER to mitochondrial contacts.
InsP 3 R1 LSKO MICE HAVE NORMAL RATES OF GLUCOSE PRODUCTION AND INSULIN SENSITIVITY
We anticipated that protection from lipid accumulation in the liver and reduced whole body adiposity might lead to differences in glucose and insulin homeostasis. In order to evaluate insulin sensitivity directly, we conducted HE clamps on adult mice fed a short-term HFD of 4 weeks. (34) During the clamp, plasma glucose concentrations and glucose infusion rates were equivalent demonstrating that whole animal insulin sensitivity is unchanged in the InsP 3 R1 LSKO mice (Fig. 4A,B) . Importantly, there was no difference in clamped plasma insulin levels between groups (data not shown). These data provide strong evidence to support the notion that loss of hepatic InsP 3 R1 does not significantly affect insulin sensitivity. In addition, basal and clamped hepatic glucose production and plasma fatty acid levels were unaltered, and clamped glucose uptake was not different either ( Fig. 4C-F) .
HEPATOCYTES FROM MICE FED AN HFD HAVE ENHANCED MITOCHONDRIAL Ca 21 RESPONSES AND ER/MITOCHONDRIA COLOCALIZATION
Given our observation that InsP 3 R1 LSKO mice are protected from hepatic steatosis, we analyzed mitochondrial Ca 21 responses to ATP stimulation in hepatocytes taken from mice chronically fed an HFD and their chow-fed littermates. We observed that HFD-fed mice had enhanced Ca 21 responses in their mitochondria (Fig. 5A ). Because InsP 3 Rs are known to serve as a conduit for Ca 21 between the ER and mitochondria, (35, 36) we examined colocalization between the two organelles using fluorescent markers, represented by the Pearson's coefficient. (37) Pearson's coefficient is a calculated value that reflects the degree of linear correlation between two numbers that range from 21 to 11. Hepatocytes from mice fed an HFD had significantly more colocalization between ER and mitochondria when compared with hepatocytes isolated from chow-fed controls (chow-fed, 0.55 6 0.03 versus HFD, 0.66 6 0.03) (Fig. 5B) . 
ER-MITOCHONDRIAL COLOCALIZATION IS INCREASED IN HUMAN FATTY LIVER
To explore the clinical relevance of transmission of calcium signals from ER to mitochondria, we measured the fraction of mitochondria that colocalized with ER in patients with fatty liver disease. First, liver biopsies from patients with histologically normal livers, simple steatosis, and NASH were stained with hematoxylin and eosin. The histology images demonstrate increased lipid content in steatosis and NASH as well as hepatocyte ballooning, inflammation, and fibrosis in the NASH samples (Fig. 6A) . Colocalization of the ER marker PDI and the mitochondrial marker Tom-22 was increased in hepatocytes in liver biopsy specimens from patients with both simple steatosis and NASH when compared with normal livers. Furthermore, colocalization, represented by Mander's coefficient, (37) was increased in NASH specimens Mander's colocalization coefficients of mitochondria to ER shows that the fraction of mitochondria associated with ER is increased in both simple steatosis (n 5 5 patients) and NASH (n 5 4) in comparison with normal liver (n 5 5) and that the coefficient for biopsies from NASH patients is significantly greater than that for patients with simple steatosis. Coefficient values are based on 25 separate determinations in each biopsy specimen. (D) InsP 3 R1 mRNA expression in human liver specimens is significantly increased in NASH patients compared with control and simple steatosis (n 5 6 biopsies per condition). Statistical significance was determined by way of analysis of variance (C) or by using a Student t test (D). All error bars represent the SEM. *P < 0.05. ***P < 0.001.
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compared with specimens with simple steatosis, suggesting a correlation with severity of disease. Mander's coefficient is a calculated value that reflects the degree of linear correlation between two numbers that range from 21 to 11 and is independent of the absolute magnitude of each variable (Fig. 6B,C) . Similar results were obtained by Pearson's coefficient. Moreover, InsP 3 R1 mRNA was increased in NASH biopsy specimens when compared with control liver biopsies (Fig.  6D) . These results suggest that there is increased association between ER and mitochondria in human fatty liver disease. It is important to note that the association increases with worsening disease severity and is associated with elevated expression of InsP 3 R1 in NASH.
Discussion
Remarkably, Ca
21
, a single ion, is able to control a multitude of cellular processes ranging from cell proliferation, (38) contraction, (39) and apoptosis (40) to gene transcription (41) and exocytosis. (42) Differing temporal properties and subcellular localization are two ways in which Ca 21 is able to regulate many processes simultaneously with precision. (43) (44) (45) Previous studies have demonstrated the importance of subcellular localization of Ca 21 signals, specifically in hepatocytes, as a high concentration of InsP 3 R2 channels under the canalicular membrane support insertion into the canalicular membrane of transporters that are important for bile secretion. (21, 22) Nuclear InsP 3 R-mediated Ca 21 signals are distinct from cytosolic signals and are important for cell proliferation and liver regeneration. (44, 46) Likewise, mitochondrial Ca 21 is a key component of cellular metabolism, (47) including in hepatocytes, (48) and regulates apoptosis in the liver as well. (49) Our previous observations with a whole body InsP 3 R2 KO mouse (23) led us to investigate the specific role of hepatic InsP 3 R1. Here, we show InsP 3 R1 has a distinct role from InsP 3 R2 in hepatocytes. This not only serves as another example of the specificity of intracellular Ca 21 as a messenger, it also shows that subcellular localization of InsP 3 R isoforms may be a critical component of the pathophysiology underlying the development of human fatty liver disease.
Fatty liver frequently occurs concomitantly with obesity and diabetes, but it can also occur independently. (50) In fact, despite recent reports implicating InsP 3 R1-mediated Ca 21 signals in hepatic glucose production and insulin sensitivity, (17, 18) we found that hepatic InsP 3 R1 was not necessary for these processes in mouse models after short-term HFD feeding, and that protection from hepatic steatosis was disconnected from glucose and insulin signaling phenotypes under the conditions of the experiments reported here. Polymorphisms in APOC3, (51) PNPLA3, (52) and TM6SF2 (53) each have been identified as risk factors for fatty liver disease. Our understanding of how each of these genes affects steatosis is evolving, but a common final pathway may relate to increased ER stress. (54, 55) Dysfunctional ER Ca 21 handling has emerged as a possible explanation for the link between lipid overload and the ER stress response. (7) Three independent groups have suggested that the cause is down-regulation of SERCA, the Ca 21 -ATPase on the ER membrane that pumps Ca 21 from the cytosol into the ER. (7, 10, 56) However, hepatic mitochondrial dysfunction driven by Ca 21 overload also contributes to the development of hepatic steatosis. (10, 11) Ca 21 uptake into the mitochondria is largely derived from the ER (36) ; therefore, it is not surprising that increased contact between the ER and mitochondria also has been implicated in the pathogenesis of hepatic steatosis. (19) InsP 3 R1 was one of the proteins shown to be up-regulated and enriched in the mitochondrial associated membranes of animal models of obesity. (19) Reducing InsP 3 R1 expression in animal models corrects the mitochondrial dysfunction associated with HFDs, (19) a finding that is consistent with our genetic liver-specific model of InsP 3 R1 deficiency, which was protected from the accumulation of lipid in the liver upon high-fat feeding. Here, we link these basic concepts to human disease by showing that patients with fatty liver have increased hepatic InsP 3 R1expression and that patients with simple steatosis and NASH have enhanced ER-mitochondrial colocalization relative to histologically normal liver. Furthermore, the degree of ER-mitochondrial colocalization correlated with severity of disease. Thus, we provide evidence from patients that corroborates work in current and previous animal models to support the role of hepatic InsP 3 R1 in the development of NAFLD. Future work may determine the extent to which aberrant InsP 3 R1 signaling is responsible for fatty liver disease in patients and explore its potential as a therapeutic target.
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